Pay in 4 interest-free payments of $5.78 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Discovery of PF-5190457, a potent, selective, and orally bioavailable ghrelin receptor inverse agonist clinical candidate
Neurological damage that has been present for more than six months may show limited or incomplete recovery, highlighting the importance of early diagnosis and treatment
Change one variable at a time to isolate which compound is responsible for any changes in symptoms or blood markers
Education, regulation and realistic planning remain central to your experience
US$ 28.10
US$ 26.59
US$ 28.96
US$ 20.82
US$ 28.17
